Bristol-Myers Squibb buy SVB Leerink LLC
Start price
12.11.24
/
50%
€56.01
Target price
12.11.25
€68.70
Performance (%)
-23.83%
End price
13.11.25
€42.67
Summary
This prediction ended on 13.11.25 with a price of €42.67. The prediction for Bristol-Myers Squibb disappointed with a performance of -23.83%. SVB_Leerink_LLC has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Dividends of €0.60 are taken into consideration when calculating the performance. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -0.770% | -0.770% | -12.975% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $73.00 price target on the stock, up previously from $55.00.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten
Current prediction by SVB_Leerink_LLC for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€48.50
13.01.26
13.01.26
€51.46
13.01.27
13.01.27
-1.74%
16.01.26
16.01.26
